Nobuko Kubota
Ina, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
From Composition to Ionic Conductivity: Machine Learning-Guided Discovery and Experimental Validation of Argyrodite-Type Lithium-Ion Electrolytes.
Journal: Small (Weinheim an der Bergstrasse, Germany)
Published: August 15, 2025
Improved prognosis of advanced-stage extranodal NK/T-cell lymphoma: results of the NKEA-Next study.
Journal: Leukemia
Published: October 04, 2024
Analyzing the risk factors for disease progression within 2 years and histological transformation in patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone as first-line treatment: A 15-year follow-up of patients with advanced follicular lymphoma in JCOG0203.
Journal: Hematological oncology
Published: December 29, 2023
R-CHOP treatment for patients with advanced follicular lymphoma: Over 15-year follow-up of JCOG0203.
R-CHOP treatment for patients with advanced follicular lymphoma: Over 15-year follow-up of JCOG0203.
Journal: British journal of haematology
Published: September 01, 2023
Prognostic impact of the UK Myeloma Research Alliance Risk Profile in transplant-ineligible patients with multiple myeloma who received a melphalan, prednisolone, and bortezomib regimen: A supplementary analysis of JCOG1105.
Journal: Hematological oncology
Published: November 23, 2022
Long-term outcomes and central nervous system relapse in extranodal natural killer/T-cell lymphoma.
Journal: Hematological oncology
Published: September 16, 2021
Single response assessment of transplant-ineligible multiple myeloma: a supplementary analysis of JCOG1105 (JCOG1105S1).
Journal: Japanese journal of clinical oncology
Published: January 28, 2021
Prophylactic antiviral therapy for hepatitis B virus surface antigen-positive patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy.
Journal: Cancer science
Published: November 24, 2020
Improved prognosis of extranodal NK/T cell lymphoma, nasal type of nasal origin but not extranasal origin.
Journal: Annals of hematology
Published: January 03, 2019
Early disease progression in patients with localized natural killer/T-cell lymphoma treated with concurrent chemoradiotherapy.
Journal: Cancer science
Published: January 02, 2018
Treatments and Outcomes of Patients With Extranodal Natural Killer/T-Cell Lymphoma Diagnosed Between 2000 and 2013: A Cooperative Study in Japan.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 31, 2016
Last Updated: 09/26/2026